Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Nov-23 5:00 PM View:  | Candel Therapeutics, Inc. (CADL) | 28-Nov-23 | Payment of Exercise | 20,153 | $0.90 | $18,137.70 | (9%) 222.16K to 202.01K | |
| 28-Nov-23 4:30 PM View: | Candel Therapeutics, Inc. (CADL) | 26-Nov-23 | Grant | 125,717 | -- | -- | 130% 96.44K to 222.16K | |
| 12-Dec-22 4:25 PM View: | Candel Therapeutics, Inc. (CADL) | 09-Dec-22 | Purchase | 2,468 | $1.93 | $4,763.24 | 80% 3.1K to 5.57K | |
| 12-Dec-22 4:25 PM View: | Candel Therapeutics, Inc. (CADL) | 08-Dec-22 | Private Purchase | 3,100 | $1.69 | $5,239.00 | 100% 0 to 3.1K | |
| 30-Nov-22 6:31 PM View: | Candel Therapeutics, Inc. (CADL) | 28-Nov-22 | Grant | 90,877 | -- | -- | 100% 0 to 90.88K | |
| 02-Mar-20 7:27 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Grant | 30,000 | -- | -- | 25% 121.62K to 151.62K | |
| 02-Mar-20 7:27 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Market Sale | 6,976 | $8.70 | $60,691.20 | (5%) 151.62K to 144.64K | 65% |
| 12-Apr-19 4:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 11-Apr-19 | Disposition | 13,148 | $7.70 | $101,240.00 | (10%) 131.77K to 118.62K | 61% |
| 05-Mar-19 10:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-19 | Grant | 65,000 | -- | -- | 97% 66.77K to 131.77K | |
| 13-Dec-18 8:08 AM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Payment of Exercise | 22,235 | $8.94 | $198,781.00 | (25%) 88.74K to 66.5K | 66% |
| 02-Mar-18 4:15 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-18 | Grant | 19,500 | -- | -- | 29% 67.74K to 87.24K | |
| 23-Feb-17 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 21-Feb-17 | Grant | 30,000 | -- | -- | 84% 35.64K to 65.64K | |
| 24-Feb-16 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 22-Feb-16 | Grant | 26,000 | -- | -- | 355% 7.33K to 33.33K | |
| 01-Dec-14 6:13 AM View: | Akebia Therapeutics, Inc. (AKBA) | 26-Nov-14 | Market Purchase | 1,000 | $13.22 | $13,220.00 | 25% 4.0K to 5.0K | (79%) |
| 27-Mar-14 4:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 25-Mar-14 | Purchase | 4,000 | $17.00 | $68,000.00 | 100% 0 to 4.0K | |
| 14-May-13 11:17 AM View: | ZIOPHARM Oncology, Inc. (TCRT) | 08-May-13 | Payment of Exercise | 2,623 | $1.65 | $4,327.95 | (10%) 25.0K to 22.38K | (125%) |
| 10-May-12 4:58 PM View: | ZIOPHARM Oncology, Inc. (TCRT) | 08-May-12 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 06-Apr-11 12:01 PM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 5,005 | $74.00 | $370,370.00 | (71%) 7.09K to 2.08K | (3%) |
| 06-Apr-11 12:01 PM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 5,005 | -- | -- | 240% 2.08K to 7.09K | |
| 06-Apr-11 12:01 PM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 2,084 | $74.00 | $154,216.00 | (100%) 2.08K to 0 | (3%) |
| 02-Sep-10 11:45 AM View: | Genzyme Corp. (GENZ) | 31-Aug-10 | Option Exercise Duplicate | 6,640 | $46.24 | $307,034.00 | 203% 3.27K to 9.91K | |
| 10-Feb-11 11:05 AM View: | Genzyme Corp. (GENZ) | 31-Aug-10 | Option Exercise | 6,640 | $46.24 | $307,034.00 | (133%) (-5.01K) to 1.63K | |
| 02-Sep-10 11:45 AM View: | Genzyme Corp. (GENZ) | 31-Aug-10 | Market Option Sale | 6,640 | $70.30 | $466,792.00 | (67%) 9.91K to 3.27K | (< 1%) |
| 10-Feb-11 11:05 AM View: | Genzyme Corp. (GENZ) | 26-Jul-10 | Market Option Sale | 1,042 | $65.25 | $67,990.50 | (39%) 2.67K to 1.63K | (12%) |
| 10-Feb-11 11:05 AM View: | Genzyme Corp. (GENZ) | 23-Jul-10 | Market Sale | 595 | $62.95 | $37,455.20 | (18%) 3.27K to 2.67K | (16%) |
| 26-May-10 5:42 PM View: | Genzyme Corp. (GENZ) | 25-May-10 | Market Option Sale | 533 | $45.62 | $24,315.50 | (14%) 3.8K to 3.27K | (12%) |
| 26-May-10 5:42 PM View: | Genzyme Corp. (GENZ) | 24-May-10 | Option Exercise | 1,575 | -- | -- | 57% 2.76K to 4.34K |